Hepatitis B virus genotype and basal core promoter/precore mutations are associated with hepatitis B-related acute-on-chronic liver failure without pre-existing liver cirrhosis

Journal of Viral Hepatitis

Volumn 17, Issue 12, 2010, Pages 887-895

  Ren, X ^a   Xu, Z ^a   Liu, Y ^a   Li, X ^a   Bai, S ^a   Ding, N ^a   Zhong, Y ^a   Wang, L ^a   Mao, P ^a   Zoulim, F ^b   Xu, D ^a  

^a BEIJING 302 HOSPITAL   (China)

^b HÔTEL DIEU   (France)

Author keywords

acute on chronic liver failure; basal core promoter; hepatitis B virus; mutation; precore

Indexed keywords

ALANINE; ALANINE AMINOTRANSFERASE; GLYCINE; HEPATITIS B(E) ANTIGEN; THREONINE; VALINE;

ADULT; AGED; ALANINE AMINOTRANSFERASE BLOOD LEVEL; AMINO ACID SUBSTITUTION; ARTICLE; CLINICAL FEATURE; CONTROLLED STUDY; FEMALE; GENE MUTATION; GENE SEQUENCE; GENOTYPE; HEPATITIS B; HEPATITIS B VIRUS; HUMAN; LIVER CIRRHOSIS; LIVER FAILURE; MAJOR CLINICAL STUDY; MALE; MORTALITY; MUTATIONAL ANALYSIS; PRIORITY JOURNAL; PROMOTER REGION; VIRUS GENE; VIRUS LOAD; VIRUS MUTANT; WILD TYPE;

ACUTE DISEASE; ADOLESCENT; ADULT; AGED; DNA, VIRAL; END STAGE LIVER DISEASE; FEMALE; GENOTYPE; HEPATITIS B; HEPATITIS B CORE ANTIGENS; HEPATITIS B VIRUS; HUMANS; LIVER CIRRHOSIS; MALE; MIDDLE AGED; MUTATION; PROMOTER REGIONS, GENETIC; PROTEIN PRECURSORS; YOUNG ADULT;

EID: 78649291026     PISSN: 13520504     EISSN: 13652893     Source Type: Journal    
DOI: 10.1111/j.1365-2893.2009.01254.x     Document Type: Article

References (40)

1. European association for the study of the liver. EASL clinical practice guidelines: management of chronic hepatitis B. J Hepatol 2009; 50: 227 - 242.
2. Liu Y, Wang CM, Cheng J, et al. Hepatitis B virus in tenofovir-naive Chinese patients with chronic hepatitis B contains no mutation of rtA194T conferring a reduced tenofovir susceptibility. Chin Med J 2009; 122: 1585 - 1586.
3. Sarin SK, Kumar A, Almeida JA, et al. Acute-on-chronic liver failure; consensus recommendations of the Asian Pacific Association for the Study of the Liver (APASL). Hepatol Int 2009; 3: 269 - 282.
4. Liver Failure and Artificial Liver Group, Chinese Society of Infectious Diseases, Chinese Medical Association; Severe Liver Diseases and Artificial Liver Group, Chinese Society of Hepatology. Diagnostic and treatment guidelines for liver failure. Chin J Hepatol (Chinese) 2006; 9: 321 - 324.
5. Zou Z, Li B, Xu D, et al. Imbalanced intrahepatic cytokine expression of interferon-γ, tumor necrosis factor-α, and interleukin-10 in patients with acute-on-chronic liver failure associated with hepatitis B virus infection. J Clin Gastroenterol 2008; 43: 182 - 190.
6. Liu Q, Liu Z, Wang T, Wang Q, Shi X, Dao W,. Characteristics of acute and sub-acute liver failure in China: nomination, classification and interval. J Gastroenterol Hepatol 2007; 22: 2101 - 2106.
7. Baumert TF, Rogers SA, Hasegawa K, Liang TJ,. Two core promoter mutation identified in a hepatitis B virus strain associated with fulminant hepatitis result in enhanced viral replication. J Clin Invest 1996; 98: 2268 - 2276.
8. Tong S, Kim KH, Chante C, Wands J, Li J,. Hepatitis B virus e antigen variants. Int J Med Sci 2005; 2: 2 - 7.
9. Kay A, Zoulim F,. Hepatitis B virus genetic variability and evolution. Virus Res 2007; 127: 164 - 167.
10. Kosaka Y, Takase K, Kojima M, et al. Fulminant hepatitis B: induction by hepatitis B virus mutants defective in the precore region and incapable of encoding e antigen. Gastroenterology 1991; 100: 1087 - 1094.
11. Sato S, Suzuki K, Akahane Y, et al. Hepatitis B virus strains with mutations in the core promoter in patients with fulminant hepatitis. Ann Intern Med 1995; 122: 241 - 248.
12. Inoue K, Yoshiba M, Sekiyama K, Okamoto H, Mayumi M,. Clinical and molecular virological difference between fulminant hepatic failures following acute and chronic infection with hepatitis B virus. J Med Virol 1998; 55: 35 - 41.
13. Friedt M, Gerner P, Lausch E, Trübel H, Zabel B, Wirth S,. Mutations in the basic core promotor and the precore region of hepatitis B virus and their selection in children with fulminant and chronic hepatitis B. Hepatology 1999; 29: 1252 - 1258.
14. Ozasa A, Tanaka Y, Orito E, et al. Influence of genotypes and precore mutations on fulminant or chronic outcome of acute hepatitis B virus infection. Hepatology 2006; 44: 326 - 343.
15. Liang TJ, Hasegawa K, Rimon N, Wands JR, Ben-Porath E,. A hepatitis B virus mutant associated with an epidemic of fulminant hepatitis. N Engl J Med 1991; 324: 1705 - 1709.
16. Parekh S, Zoulim F, Ahn SH, et al. Genome replication, virion secretion, and e antigen expression of naturally occurring hepatitis B virus core promoter mutants. J Virol 2003; 77: 6601 - 6611.
17. Hou J, Lin Y, Waters J, et al. Detection and significance of a G1862T variant of hepatitis B virus in Chinese patients with fulminant hepatitis. J Gen Virol 2002; 83: 2291 - 2298.
18. Sainokami S, Abe K, Sato A, et al. Initial load of hepatitis B virus (HBV), its changing profile, and precore/core promoter mutations correlate with the severity and outcome of acute HBV infection. J Gastroenterol 2007; 42: 241 - 249.
19. Wai CT, Fontana RJ, Polson J, Hussain M, Shakil AO, Han SH,. Clinical outcome and virological characteristics of hepatitis B-related acute liver failure in the United States. J Viral Hepat 2005; 12: 192 - 198.
20. Sterneck M, Günther S, Santantonio T, et al. Hepatitis B virus genomes of patients with fulminant hepatitis do not share a specific mutation. Hepatology 1996; 24: 300 - 306.
21. Yuasa R, Takahashi K, Dien BV, et al. Properties of hepatitis B virus genome recovered from Vietnamese patients with fulminant hepatitis in comparison with those of acute hepatitis. J Med Virol 2000; 61: 23 - 28.
22. Chun YK, Kim JY, Woo HJ, et al. No significant correlation exists between core promoter mutations, viral replication and liver damage in chronic hepatitis B infection. Hepatology 2005; 32: 1154 - 1162.
23. Gandhe SS, Chadha MS, Walimbe AM, Arankalle VA,. Hepatitia B virus: prevalence of precore/core promoter mutants in different clinical categories of Indian patients. J Viral Hepat 2003; 10: 367 - 382.
24. Liu CJ, Kao JH, Lai MY, Chen PJ, Chen DS,. Precore/core promoter mutations and genotypes of hepatitis B virus in chronic hepatitis B patients with fulminant or subfulminant hepatitis. J Med Virol 2004; 72: 545 - 550.
25. Günther S, Piwon N, Iwanska A, Schilling R, Meisel H, Will H,. Type, prevalence, and significance of core promoter/enhancer II mutations in hepatitis B viruses from immunosuppressed patients with severe liver disease. J Virol 1996; 70: 8318 - 8331.
26. Preikschat P, Günther S, Reinhold S, et al. Complex HBV populations with mutations in core promoter, C gene, and pre-S region are associated with development of cirrhosis in long-term renal transplant recipients. Hepatology 2002; 35: 466 - 477.
27. Sugauchi F, Orito E, Ohno T, et al. Spatial and chronological differences in hepatitis B virus genotypes from patients with acute hepatitis B in Japan. Hepatol Res 2006; 36: 107 - 114.
28. Chinese Society of Infectious Diseases and Parasitology, and the Chinese Society of Hepatology, of the Chinese Medical Association. Management scheme of diagnostic and therapy criteria of viral hepatitis. Zhonghua Gan Zang Bing Za Zhi (Chin J Hepatol) 2000; 8: 324 - 329.
29. Fang ZL, Sabin CA, Dong BQ, et al. The association of HBV core promoter double mutations (A1762T and G1764A) with viral load differs between HBeAg positive and anti-HBe positive individuals: a longitudinal analysis. J Hepatol 2009; 50: 273 - 280.
30. Bartholomeusz A, Locarnini S,. Editorial. Hepatitis B virus mutants and fulminant hepatitis B: fitness plus phenotype. Hepatology 2001; 34: 432 - 435.
31. Tsai WL, Lo GH, Hsu PI, et al. Role of genotype and precore/basal core promoter mutations of hepatitis B virus in patients with chronic hepatitis with acute exacerbation. Scand J Gastroenterol 2008; 43: 196 - 201.
32. Kusumoto K, Yatsuhashi H, Nakao R, Hamada R, Fukuda M, Tamada Y,. Detection of HBV core promoter and precore mutations helps distinguish flares of chronic hepatitis from acute hepatitis B. J Gastroenterol Hepatol 2008; 23: 790 - 793.
33. Yuen MF, Sablon E, Tanaka Y, et al. Epidemiological study of hepatitis B virus genotypes, core promoter and precore mutations of chronic hepatitis B infection in Hong Kong. J Hepatol 2004; 41: 119 - 125. (Pubitemid 39005162)
34. Kramvis A, Kew MC,. Relationship of genotypes of hepatitis B virus to mutations, disease progression and response to antiviral therapy. J Viral Hepat 2005; 12: 456 - 464.
35. Chauhan R, Kazim SN, Bhattacharjee J, Sakhuja P, Sarin SK,. Basal core promoter, precore region mutations of HBV and their association with e antigen, genotype, and severity of liver disease in patients with chronic hepatitis B in India. J Med Virol 2006; 78: 1047 - 1054.
36. Jammeh S, Tavner F, Watson R, Thomas HC, Karayiannis P,. Effect of basal core promoter and pre-core mutations on hepatitis B virus replication. J Gen Virol 2008; 89: 901 - 909.
37. Guo X, Jin Y, Qian G, Tu H,. Sequential accumulation of the mutations in core promoter of hepatitis B virus is associated with the development of hepatocellular carcinoma in Qidong, China. J Hepatol 2008; 49: 718 - 725.
38. Kalinina T, Riu A, Fischer L, Santantonio T, Will H, Sterneck M,. Selection of a secretion-incompetent mutant in the serum of a patient with severe hepatitis B. Gastroenterology 2003; 125: 1077 - 1084.
39. O'Grady JG, Alexander GJ, Hayllar KM, Williams R,. Early indicators of prognosis in fulminant hepatic failure. Gastroenterology 1989; 97: 439 - 445. (Pubitemid 19192181)
40. Bernuau J, Goudeau A, Poynard T, et al. Multivariate analysis of prognostic factors in fulminant hepatitis B. Hepatology 1986; 6: 648 - 651.